カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の即効性喘息薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Quick-acting Asthma Medicine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19583）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19583
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の即効性喘息薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

即効性喘息薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の即効性喘息薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

即効性喘息薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・錠剤、スプレー

用途別セグメントは次のように区分されます。
・病院薬局、オンライン薬局、小売薬局

世界の即効性喘息薬市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、GlaxoSmithKline、Novartis、Merck、Boehringer Ingelheim、AstraZeneca、Roche、Teva Pharmaceutical、Vectura Group

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、即効性喘息薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な即効性喘息薬メーカーの企業概要、2019年～2022年までの即効性喘息薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な即効性喘息薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別即効性喘息薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの即効性喘息薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での即効性喘息薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および即効性喘息薬の産業チェーンを掲載しています。
・第13、14、15章では、即効性喘息薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 即効性喘息薬の概要
- 種類別分析（2017年vs2021年vs2028年）：錠剤、スプレー
- 用途別分析（2017年vs2021年vs2028年）：病院薬局、オンライン薬局、小売薬局
- 世界の即効性喘息薬市場規模・予測
- 世界の即効性喘息薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、GlaxoSmithKline、Novartis、Merck、Boehringer Ingelheim、AstraZeneca、Roche、Teva Pharmaceutical、Vectura Group
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：錠剤、スプレー
・用途別分析2017年-2028年：病院薬局、オンライン薬局、小売薬局
・即効性喘息薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・即効性喘息薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・即効性喘息薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・即効性喘息薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・即効性喘息薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Quick-acting Asthma Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Quick-acting Asthma Medicine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacy accounting for % of the Quick-acting Asthma Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Quick-acting Asthma Medicine include Pfizer, GlaxoSmithKline, Novartis, Merck, and Boehringer Ingelheim, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Quick-acting Asthma Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet
Spray
Market segment by Application can be divided into
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
The key market players for global Quick-acting Asthma Medicine market are listed below:
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Quick-acting Asthma Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Quick-acting Asthma Medicine, with price, sales, revenue and global market share of Quick-acting Asthma Medicine from 2019 to 2022.
Chapter 3, the Quick-acting Asthma Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Quick-acting Asthma Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Quick-acting Asthma Medicine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Quick-acting Asthma Medicine.
Chapter 13, 14, and 15, to describe Quick-acting Asthma Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Quick-acting Asthma Medicine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Quick-acting Asthma Medicine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tablet
1.2.3 Spray
1.3 Market Analysis by Application
1.3.1 Overview: Global Quick-acting Asthma Medicine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Global Quick-acting Asthma Medicine Market Size & Forecast
1.4.1 Global Quick-acting Asthma Medicine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Quick-acting Asthma Medicine Sales in Volume (2017-2028)
1.4.3 Global Quick-acting Asthma Medicine Price (2017-2028)
1.5 Global Quick-acting Asthma Medicine Production Capacity Analysis
1.5.1 Global Quick-acting Asthma Medicine Total Production Capacity (2017-2028)
1.5.2 Global Quick-acting Asthma Medicine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Quick-acting Asthma Medicine Market Drivers
1.6.2 Quick-acting Asthma Medicine Market Restraints
1.6.3 Quick-acting Asthma Medicine Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Quick-acting Asthma Medicine Product and Services
2.1.4 Pfizer Quick-acting Asthma Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Quick-acting Asthma Medicine Product and Services
2.2.4 GlaxoSmithKline Quick-acting Asthma Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Quick-acting Asthma Medicine Product and Services
2.3.4 Novartis Quick-acting Asthma Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Quick-acting Asthma Medicine Product and Services
2.4.4 Merck Quick-acting Asthma Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Quick-acting Asthma Medicine Product and Services
2.5.4 Boehringer Ingelheim Quick-acting Asthma Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Quick-acting Asthma Medicine Product and Services
2.6.4 AstraZeneca Quick-acting Asthma Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Quick-acting Asthma Medicine Product and Services
2.7.4 Roche Quick-acting Asthma Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business
2.8.3 Teva Pharmaceutical Quick-acting Asthma Medicine Product and Services
2.8.4 Teva Pharmaceutical Quick-acting Asthma Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Vectura Group
2.9.1 Vectura Group Details
2.9.2 Vectura Group Major Business
2.9.3 Vectura Group Quick-acting Asthma Medicine Product and Services
2.9.4 Vectura Group Quick-acting Asthma Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Quick-acting Asthma Medicine Breakdown Data by Manufacturer
3.1 Global Quick-acting Asthma Medicine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Quick-acting Asthma Medicine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Quick-acting Asthma Medicine
3.4 Market Concentration Rate
3.4.1 Top 3 Quick-acting Asthma Medicine Manufacturer Market Share in 2021
3.4.2 Top 6 Quick-acting Asthma Medicine Manufacturer Market Share in 2021
3.5 Global Quick-acting Asthma Medicine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Quick-acting Asthma Medicine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Quick-acting Asthma Medicine Market Size by Region
4.1.1 Global Quick-acting Asthma Medicine Sales in Volume by Region (2017-2028)
4.1.2 Global Quick-acting Asthma Medicine Revenue by Region (2017-2028)
4.2 North America Quick-acting Asthma Medicine Revenue (2017-2028)
4.3 Europe Quick-acting Asthma Medicine Revenue (2017-2028)
4.4 Asia-Pacific Quick-acting Asthma Medicine Revenue (2017-2028)
4.5 South America Quick-acting Asthma Medicine Revenue (2017-2028)
4.6 Middle East and Africa Quick-acting Asthma Medicine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Quick-acting Asthma Medicine Sales in Volume by Type (2017-2028)
5.2 Global Quick-acting Asthma Medicine Revenue by Type (2017-2028)
5.3 Global Quick-acting Asthma Medicine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Quick-acting Asthma Medicine Sales in Volume by Application (2017-2028)
6.2 Global Quick-acting Asthma Medicine Revenue by Application (2017-2028)
6.3 Global Quick-acting Asthma Medicine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Quick-acting Asthma Medicine Sales by Type (2017-2028)
7.2 North America Quick-acting Asthma Medicine Sales by Application (2017-2028)
7.3 North America Quick-acting Asthma Medicine Market Size by Country
7.3.1 North America Quick-acting Asthma Medicine Sales in Volume by Country (2017-2028)
7.3.2 North America Quick-acting Asthma Medicine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Quick-acting Asthma Medicine Sales by Type (2017-2028)
8.2 Europe Quick-acting Asthma Medicine Sales by Application (2017-2028)
8.3 Europe Quick-acting Asthma Medicine Market Size by Country
8.3.1 Europe Quick-acting Asthma Medicine Sales in Volume by Country (2017-2028)
8.3.2 Europe Quick-acting Asthma Medicine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Quick-acting Asthma Medicine Sales by Type (2017-2028)
9.2 Asia-Pacific Quick-acting Asthma Medicine Sales by Application (2017-2028)
9.3 Asia-Pacific Quick-acting Asthma Medicine Market Size by Region
9.3.1 Asia-Pacific Quick-acting Asthma Medicine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Quick-acting Asthma Medicine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Quick-acting Asthma Medicine Sales by Type (2017-2028)
10.2 South America Quick-acting Asthma Medicine Sales by Application (2017-2028)
10.3 South America Quick-acting Asthma Medicine Market Size by Country
10.3.1 South America Quick-acting Asthma Medicine Sales in Volume by Country (2017-2028)
10.3.2 South America Quick-acting Asthma Medicine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Quick-acting Asthma Medicine Sales by Type (2017-2028)
11.2 Middle East & Africa Quick-acting Asthma Medicine Sales by Application (2017-2028)
11.3 Middle East & Africa Quick-acting Asthma Medicine Market Size by Country
11.3.1 Middle East & Africa Quick-acting Asthma Medicine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Quick-acting Asthma Medicine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Quick-acting Asthma Medicine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Quick-acting Asthma Medicine
12.3 Quick-acting Asthma Medicine Production Process
12.4 Quick-acting Asthma Medicine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Quick-acting Asthma Medicine Typical Distributors
13.3 Quick-acting Asthma Medicine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Quick-acting Asthma Medicine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Quick-acting Asthma Medicine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Quick-acting Asthma Medicine Product and Services
Table 6. Pfizer Quick-acting Asthma Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Quick-acting Asthma Medicine Product and Services
Table 10. GlaxoSmithKline Quick-acting Asthma Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Quick-acting Asthma Medicine Product and Services
Table 14. Novartis Quick-acting Asthma Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Quick-acting Asthma Medicine Product and Services
Table 18. Merck Quick-acting Asthma Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Major Business
Table 21. Boehringer Ingelheim Quick-acting Asthma Medicine Product and Services
Table 22. Boehringer Ingelheim Quick-acting Asthma Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Quick-acting Asthma Medicine Product and Services
Table 26. AstraZeneca Quick-acting Asthma Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Roche Basic Information, Manufacturing Base and Competitors
Table 28. Roche Major Business
Table 29. Roche Quick-acting Asthma Medicine Product and Services
Table 30. Roche Quick-acting Asthma Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceutical Major Business
Table 33. Teva Pharmaceutical Quick-acting Asthma Medicine Product and Services
Table 34. Teva Pharmaceutical Quick-acting Asthma Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Vectura Group Basic Information, Manufacturing Base and Competitors
Table 36. Vectura Group Major Business
Table 37. Vectura Group Quick-acting Asthma Medicine Product and Services
Table 38. Vectura Group Quick-acting Asthma Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Quick-acting Asthma Medicine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Quick-acting Asthma Medicine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Quick-acting Asthma Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Quick-acting Asthma Medicine Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Quick-acting Asthma Medicine Production Site of Key Manufacturer
Table 44. Quick-acting Asthma Medicine New Entrant and Capacity Expansion Plans
Table 45. Quick-acting Asthma Medicine Mergers & Acquisitions in the Past Five Years
Table 46. Global Quick-acting Asthma Medicine Sales by Region (2017-2022) & (K Units)
Table 47. Global Quick-acting Asthma Medicine Sales by Region (2023-2028) & (K Units)
Table 48. Global Quick-acting Asthma Medicine Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Quick-acting Asthma Medicine Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Quick-acting Asthma Medicine Sales by Type (2017-2022) & (K Units)
Table 51. Global Quick-acting Asthma Medicine Sales by Type (2023-2028) & (K Units)
Table 52. Global Quick-acting Asthma Medicine Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Quick-acting Asthma Medicine Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Quick-acting Asthma Medicine Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Quick-acting Asthma Medicine Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Quick-acting Asthma Medicine Sales by Application (2017-2022) & (K Units)
Table 57. Global Quick-acting Asthma Medicine Sales by Application (2023-2028) & (K Units)
Table 58. Global Quick-acting Asthma Medicine Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Quick-acting Asthma Medicine Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Quick-acting Asthma Medicine Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Quick-acting Asthma Medicine Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Quick-acting Asthma Medicine Sales by Country (2017-2022) & (K Units)
Table 63. North America Quick-acting Asthma Medicine Sales by Country (2023-2028) & (K Units)
Table 64. North America Quick-acting Asthma Medicine Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Quick-acting Asthma Medicine Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Quick-acting Asthma Medicine Sales by Type (2017-2022) & (K Units)
Table 67. North America Quick-acting Asthma Medicine Sales by Type (2023-2028) & (K Units)
Table 68. North America Quick-acting Asthma Medicine Sales by Application (2017-2022) & (K Units)
Table 69. North America Quick-acting Asthma Medicine Sales by Application (2023-2028) & (K Units)
Table 70. Europe Quick-acting Asthma Medicine Sales by Country (2017-2022) & (K Units)
Table 71. Europe Quick-acting Asthma Medicine Sales by Country (2023-2028) & (K Units)
Table 72. Europe Quick-acting Asthma Medicine Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Quick-acting Asthma Medicine Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Quick-acting Asthma Medicine Sales by Type (2017-2022) & (K Units)
Table 75. Europe Quick-acting Asthma Medicine Sales by Type (2023-2028) & (K Units)
Table 76. Europe Quick-acting Asthma Medicine Sales by Application (2017-2022) & (K Units)
Table 77. Europe Quick-acting Asthma Medicine Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Quick-acting Asthma Medicine Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Quick-acting Asthma Medicine Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Quick-acting Asthma Medicine Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Quick-acting Asthma Medicine Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Quick-acting Asthma Medicine Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Quick-acting Asthma Medicine Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Quick-acting Asthma Medicine Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Quick-acting Asthma Medicine Sales by Application (2023-2028) & (K Units)
Table 86. South America Quick-acting Asthma Medicine Sales by Country (2017-2022) & (K Units)
Table 87. South America Quick-acting Asthma Medicine Sales by Country (2023-2028) & (K Units)
Table 88. South America Quick-acting Asthma Medicine Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Quick-acting Asthma Medicine Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Quick-acting Asthma Medicine Sales by Type (2017-2022) & (K Units)
Table 91. South America Quick-acting Asthma Medicine Sales by Type (2023-2028) & (K Units)
Table 92. South America Quick-acting Asthma Medicine Sales by Application (2017-2022) & (K Units)
Table 93. South America Quick-acting Asthma Medicine Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Quick-acting Asthma Medicine Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Quick-acting Asthma Medicine Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Quick-acting Asthma Medicine Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Quick-acting Asthma Medicine Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Quick-acting Asthma Medicine Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Quick-acting Asthma Medicine Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Quick-acting Asthma Medicine Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Quick-acting Asthma Medicine Sales by Application (2023-2028) & (K Units)
Table 102. Quick-acting Asthma Medicine Raw Material
Table 103. Key Manufacturers of Quick-acting Asthma Medicine Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Quick-acting Asthma Medicine Typical Distributors
Table 107. Quick-acting Asthma Medicine Typical Customers
List of Figures
Figure 1. Quick-acting Asthma Medicine Picture
Figure 2. Global Quick-acting Asthma Medicine Revenue Market Share by Type in 2021
Figure 3. Tablet
Figure 4. Spray
Figure 5. Global Quick-acting Asthma Medicine Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacy
Figure 7. Online Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Global Quick-acting Asthma Medicine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Quick-acting Asthma Medicine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Quick-acting Asthma Medicine Sales (2017-2028) & (K Units)
Figure 12. Global Quick-acting Asthma Medicine Price (2017-2028) & (US$/Unit)
Figure 13. Global Quick-acting Asthma Medicine Production Capacity (2017-2028) & (K Units)
Figure 14. Global Quick-acting Asthma Medicine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Quick-acting Asthma Medicine Market Drivers
Figure 16. Quick-acting Asthma Medicine Market Restraints
Figure 17. Quick-acting Asthma Medicine Market Trends
Figure 18. Global Quick-acting Asthma Medicine Sales Market Share by Manufacturer in 2021
Figure 19. Global Quick-acting Asthma Medicine Revenue Market Share by Manufacturer in 2021
Figure 20. Quick-acting Asthma Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Quick-acting Asthma Medicine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Quick-acting Asthma Medicine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Quick-acting Asthma Medicine Sales Market Share by Region (2017-2028)
Figure 24. Global Quick-acting Asthma Medicine Revenue Market Share by Region (2017-2028)
Figure 25. North America Quick-acting Asthma Medicine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Quick-acting Asthma Medicine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Quick-acting Asthma Medicine Revenue (2017-2028) & (USD Million)
Figure 28. South America Quick-acting Asthma Medicine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Quick-acting Asthma Medicine Revenue (2017-2028) & (USD Million)
Figure 30. Global Quick-acting Asthma Medicine Sales Market Share by Type (2017-2028)
Figure 31. Global Quick-acting Asthma Medicine Revenue Market Share by Type (2017-2028)
Figure 32. Global Quick-acting Asthma Medicine Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Quick-acting Asthma Medicine Sales Market Share by Application (2017-2028)
Figure 34. Global Quick-acting Asthma Medicine Revenue Market Share by Application (2017-2028)
Figure 35. Global Quick-acting Asthma Medicine Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Quick-acting Asthma Medicine Sales Market Share by Type (2017-2028)
Figure 37. North America Quick-acting Asthma Medicine Sales Market Share by Application (2017-2028)
Figure 38. North America Quick-acting Asthma Medicine Sales Market Share by Country (2017-2028)
Figure 39. North America Quick-acting Asthma Medicine Revenue Market Share by Country (2017-2028)
Figure 40. United States Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Quick-acting Asthma Medicine Sales Market Share by Type (2017-2028)
Figure 44. Europe Quick-acting Asthma Medicine Sales Market Share by Application (2017-2028)
Figure 45. Europe Quick-acting Asthma Medicine Sales Market Share by Country (2017-2028)
Figure 46. Europe Quick-acting Asthma Medicine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Quick-acting Asthma Medicine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Quick-acting Asthma Medicine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Quick-acting Asthma Medicine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Quick-acting Asthma Medicine Revenue Market Share by Region (2017-2028)
Figure 56. China Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Quick-acting Asthma Medicine Sales Market Share by Type (2017-2028)
Figure 63. South America Quick-acting Asthma Medicine Sales Market Share by Application (2017-2028)
Figure 64. South America Quick-acting Asthma Medicine Sales Market Share by Country (2017-2028)
Figure 65. South America Quick-acting Asthma Medicine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Quick-acting Asthma Medicine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Quick-acting Asthma Medicine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Quick-acting Asthma Medicine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Quick-acting Asthma Medicine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Quick-acting Asthma Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Quick-acting Asthma Medicine in 2021
Figure 77. Manufacturing Process Analysis of Quick-acting Asthma Medicine
Figure 78. Quick-acting Asthma Medicine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 即効性喘息治療薬の世界市場2023年：錠剤、スプレー
  • 単動クイックリリースピンのグローバル市場展望 2023年-2029年：ボタンハンドルクイックリリースピン、Lハンドルクイックリリースピン、Tハンドルクイックリリースピン、その他
  • 世界の喘息治療薬市場2022年：市場規模予測（～2028年）
  • 世界の喘息治療装置市場2022年：市場規模予測（～2028年）
  • 世界の飛行機クイックロックピン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19583 )"世界の即効性喘息薬市場2022年：市場規模予測（～2028年）" (英文：Global Quick-acting Asthma Medicine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。